On The Pulse Director, Laurence Woollard, MSc, has written a commentary for the Association of the British Pharmaceutical Industry (ABPI) in recognition of Rare Disease Day 2026, which this year focuses on equity.
Titled ‘Equity in the age of advanced therapies: insights from haemophilia’, the piece examines how advanced therapy medicinal products (ATMPs), including gene and cell therapies, are entering routine NHS care – using haemophilia as a lens to explore questions of access, benefit–risk and real-world implementation.
Read the full article on the ABPI website here.
Acknowledgements
With thanks to Kirsty Gelsthorpe and the ABPI team for the invitation to contribute, together with Will Horsley, Professor Charlie Hay and Dr Rich Gorman for their input into the article.
Get in touch
For all work-related enquiries, please email Laurence at: info@onthepulseconsultancy.com